Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting
Journal of Cancer Research and Clinical Oncology · 2023-08 · 149 (9) · 6283-6291
DOI: 10.1007/s00432-023-04597-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 01.02.2023. Verfasst von Alison Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Menter Dermatology Research Institute, Baylor University Medical Center, Dallas, TX, USA. atran@menterderm.com. Hauptthemen laut MEDLINE: Dermatology, Skin Neoplasms, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Interest in image-guidance superficial radiation therapy (IGSRT) for the treatment of early-stage non-melanoma skin cancer (NMSC) has resurfaced given its low complication rates, superior cosmesis and local control and cure rates. In addition, it has been recommended by the American Academy of Dermatology (AAD) for early-stage NMSC in patients who are considered poor surgical candidates.
Methods
1899 NMSC lesions were treated with energies ranging from 50 to 100 kilovoltage (kV), for a mean of 20.2 fractions, and treatment dose of 5364.4 centigray (cGy). Lesions were treated for a mean of 7.5 weeks and followed for 65.5 weeks. SAS studio was used to conduct Kaplan–Meier analysis to calculate local control rates and account for differences in follow-up intervals. A log-rank test was used to calculate statistical differences between histologies.
Results
Absolute lesion control was achieved in 99.7% of the patients after an average of 7.5 weeks of treatment, with a stable control rate of 99.6% when the follow-up duration was over 12 months. 95% of lesions with toxicity scoring received a Radiation Treatment Oncology Group Toxicity (RTOG) score of 1 or 2.
Conclusion
IGSRT has a high safety profile, can achieve superior cosmesis and should be considered first-line for treating early-stage NMSC tumors as cure rates have been shown to be effective in all NMSC on early follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Menter Dermatology Research Institute, Baylor University Medical Center, Dallas, TX, USA. atran@menterderm.com.
- Heights Dermatology, Houston, TX, USA. atran@menterderm.com.
- New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
- Stony Brook University, Stony Brook, NY, USA.
- Menter Dermatology Research Institute, Baylor University Medical Center, Dallas, TX, USA.
- Heights Dermatology, Houston, TX, USA.
Zitieren
APA
Tran, A., Moloney, M., Kaczmarski, P., Zheng, S., Desai, A., Desai, T., & Yu, L. (2023). Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting. Journal of Cancer Research and Clinical Oncology, 149(9), 6283-6291. https://doi.org/10.1007/s00432-023-04597-2
Vancouver
Tran A, Moloney M, Kaczmarski P, Zheng S, Desai A, Desai T, et al. Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting. Journal of Cancer Research and Clinical Oncology. 2023;149(9):6283-6291. doi:10.1007/s00432-023-04597-2
BibTeX
@article{Tran2023,
author = {Tran, Alison and Moloney, Mairead and Kaczmarski, Peter and Zheng, Songzhu and Desai, Alpesh and Desai, Tejas and Yu, Lio},
title = {Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2023},
volume = {149},
number = {9},
pages = {6283--6291},
doi = {10.1007/s00432-023-04597-2}
}
EUVIMED